Skip to lesson
OncoGuideeducationDiana’s wiki
THE EDUCATION LIBRARY

Immune escape

In one sentence

Immune escape occurs when cancer cells survive by avoiding recognition, access or effective immune attack.

The intuition

A pursuit can fail because the address changed, the road is blocked or the responders cannot act. These are different obstacles. “Escape” describes an outcome and its possible mechanisms; it does not identify the next treatment automatically.

How it works

Cancer cells may lose an antigen, a presenting human leukocyte antigen (HLA) allele or shared antigen-processing machinery. Changes in expression can be reversible, while a deletion changes the underlying sequence. Losing one allele and impairing many class-I complexes are different events.

Tumor vessels, surrounding matrix and local signals can limit immune-cell entry. Suppressive cells and signals can also reduce function after entry. Several obstacles may coexist within one tumor or differ between disease sites.

Treatment may select a pre-existing resistant population. New changes can also arise over time. Finding a variant in resistant tissue does not establish that it caused resistance; earlier samples, appropriate controls and functional evidence help test the hypothesis.

Why it matters in cancer

Combining therapies may address distinct bottlenecks, share a failure point or add toxicity. An attractive diagram of complementary mechanisms does not establish clinical benefit or a safe combination.

Worked example

A fictional tumor keeps an antigen but loses the HLA allele used by an engineered receptor. More cells with that receptor do not restore the missing display route. A different recognition strategy creates new target, safety and evidence questions rather than an automatic rescue.

Common confusions

  • HLA-independent recognition is not resistance-free treatment.
  • A blood tumor-DNA result does not reveal a particular immune-escape mechanism.
  • A mechanism observed in one relapse does not establish its frequency in all cancers.

Sources and scope

Source check: October 8, 2026. This is a mechanism explanation, not a treatment recommendation. Expert and learner review remain pending.

Used in